151 related articles for article (PubMed ID: 36924377)
1. Stage I seminoma: Outcome of different treatment modalities and changes in patterns of care. A single institution experience.
Mahmoud Sayed M; Nasr AM; Saad Eldin IM; Abdelazim YA
Arch Ital Urol Androl; 2023 Feb; 95(1):11057. PubMed ID: 36924377
[TBL] [Abstract][Full Text] [Related]
2. Management of clinical stage I testicular pure seminoma. Report on 42 patients and review of the literature.
Porcaro AB; Antoniolli SZ; Schiavone D; Maffei N; Bassetto MA; Curti P
Arch Ital Urol Androl; 2002 Jun; 74(2):77-80. PubMed ID: 12161941
[TBL] [Abstract][Full Text] [Related]
3. Clinical Characteristics and Outcomes of Late Relapse in Stage I Testicular Seminoma.
Hosni A; Warde P; Jewett M; Bedard P; Hamilton R; Moore M; Nayan M; Huang R; Atenafu EG; O'Malley M; Sweet J; Chung P
Clin Oncol (R Coll Radiol); 2016 Oct; 28(10):648-54. PubMed ID: 27339401
[TBL] [Abstract][Full Text] [Related]
4. Management of testicular seminoma advanced disease. Report on 14 cases and review of the literature.
Porcaro AB; Antoniolli SZ; Maffei N; Beltrami P; Bassetto MA; Curti P
Arch Ital Urol Androl; 2002 Jun; 74(2):81-5. PubMed ID: 12161942
[TBL] [Abstract][Full Text] [Related]
5. Treatment preferences in stage IA and IB testicular seminoma: multicenter study of Anatolian Society of Medical Oncology.
Bilici A; Ozturk T; Turkmen E; Odabas H; Cihan S; Selcukbiricik F; Erdogan B; Urakci Z; Kandemir N; Bayoglu IV; Demirci U; Duran AO; Sendur MA; Yavuzer D; Harputluoglu H; Kavgaci H; Gumus M
World J Urol; 2015 Oct; 33(10):1613-22. PubMed ID: 25605506
[TBL] [Abstract][Full Text] [Related]
6. Multicenter study evaluating a dual policy of postorchiectomy surveillance and selective adjuvant single-agent carboplatin for patients with clinical stage I seminoma.
Aparicio J; García del Muro X; Maroto P; Paz-Ares L; Alba E; Sáenz A; Terrasa J; Barnadas A; Almenar D; Arranz JA; Sánchez M; Fernández A; Sastre J; Carles J; Dorca J; Gumà J; Yuste AL; Germà JR;
Ann Oncol; 2003 Jun; 14(6):867-72. PubMed ID: 12796024
[TBL] [Abstract][Full Text] [Related]
7. Treatment outcome and patterns of relapse following adjuvant carboplatin for stage I testicular seminomatous germ-cell tumour: results from a 17-year UK experience.
Chau C; Cathomas R; Wheater M; Klingbiel D; Fehr M; Bennett J; Markham H; Lee C; Crabb SJ; Geldart T
Ann Oncol; 2015 Sep; 26(9):1865-1870. PubMed ID: 26037797
[TBL] [Abstract][Full Text] [Related]
8. Personalizing, not patronizing: the case for patient autonomy by unbiased presentation of management options in stage I testicular cancer.
Oldenburg J; Aparicio J; Beyer J; Cohn-Cedermark G; Cullen M; Gilligan T; De Giorgi U; De Santis M; de Wit R; Fosså SD; Germà-Lluch JR; Gillessen S; Haugnes HS; Honecker F; Horwich A; Lorch A; Ondruš D; Rosti G; Stephenson AJ; Tandstad T
Ann Oncol; 2015 May; 26(5):833-838. PubMed ID: 25378299
[TBL] [Abstract][Full Text] [Related]
9. Management and outcomes of clinical stage IIA/B seminoma: Results from the National Cancer Data Base 1998-2012.
Paly JJ; Lin CC; Gray PJ; Hallemeier CL; Beard C; Sineshaw H; Jemal A; Efstathiou JA
Pract Radiat Oncol; 2016; 6(6):e249-e258. PubMed ID: 27345128
[TBL] [Abstract][Full Text] [Related]
10. Management of Low-Stage Testicular Seminoma.
Pearce SM; Liauw SL; Eggener SE
Urol Clin North Am; 2015 Aug; 42(3):287-98. PubMed ID: 26216816
[TBL] [Abstract][Full Text] [Related]
11. [Alternatives to the radiotherapy of stage I testicular seminoma].
Paule B
Bull Cancer; 2005 Mar; 92(3):267-71. PubMed ID: 15820921
[TBL] [Abstract][Full Text] [Related]
12. Outcome of Men With Relapse After Adjuvant Carboplatin for Clinical Stage I Seminoma.
Fischer S; Tandstad T; Wheater M; Porfiri E; Fléchon A; Aparicio J; Klingbiel D; Skrbinc B; Basso U; Shamash J; Lorch A; Dieckmann KP; Cohn-Cedermark G; Ståhl O; Chau C; Arriola E; Marti K; Hutton P; Laguerre B; Maroto P; Beyer J; Gillessen S
J Clin Oncol; 2017 Jan; 35(2):194-200. PubMed ID: 27893332
[TBL] [Abstract][Full Text] [Related]
13. Adjuvant radiotherapy for Stage I seminoma: A Single-institutional experience.
Kanyilmaz G; Saricanbaz I; Bora H; Karahacioglu E; Erkal EY
J Cancer Res Ther; 2019 Mar; 15(Supplement):S87-S90. PubMed ID: 30900627
[TBL] [Abstract][Full Text] [Related]
14. Exploration of treatment options for the management of stage I testicular seminoma.
Bernal F; Raman JD
Expert Rev Anticancer Ther; 2008 Jul; 8(7):1081-90. PubMed ID: 18588453
[TBL] [Abstract][Full Text] [Related]
15. Carboplatin in clinical stage I seminoma: too much and too little at the same time.
Bosl GJ; Patil S
J Clin Oncol; 2011 Mar; 29(8):949-52. PubMed ID: 21282532
[No Abstract] [Full Text] [Related]
16. Outcomes of surveillance versus adjuvant treatment for patients with stage-I seminoma: a single-center experience.
Akdag G; Alan O; Dogan A; Yuksel Z; Yildirim S; Kinikoglu O; Kudu E; Surmeli H; Odabas H; Yildirim ME; Turan N
World J Urol; 2023 Aug; 41(8):2201-2207. PubMed ID: 37351618
[TBL] [Abstract][Full Text] [Related]
17. Oncological outcomes in patients with stage I testicular seminoma and nonseminoma: pathological risk factors for relapse and feasibility of surveillance after orchiectomy.
Kobayashi K; Saito T; Kitamura Y; Nobushita T; Kawasaki T; Hara N; Takahashi K
Diagn Pathol; 2013 Apr; 8():57. PubMed ID: 23566361
[TBL] [Abstract][Full Text] [Related]
18. Risk factors for loss to follow-up during active surveillance of patients with Stage I seminoma.
Endo T; Kawai K; Kamba T; Inai H; Uchida K; Miyazaki J; Kamoto T; Ogawa O; Nishiyama H
Jpn J Clin Oncol; 2014 Apr; 44(4):355-9. PubMed ID: 24558127
[TBL] [Abstract][Full Text] [Related]
19. Randomized trial of carboplatin versus radiotherapy for stage I seminoma: mature results on relapse and contralateral testis cancer rates in MRC TE19/EORTC 30982 study (ISRCTN27163214).
Oliver RT; Mead GM; Rustin GJ; Joffe JK; Aass N; Coleman R; Gabe R; Pollock P; Stenning SP
J Clin Oncol; 2011 Mar; 29(8):957-62. PubMed ID: 21282539
[TBL] [Abstract][Full Text] [Related]
20. Adjuvant treatment for Stage I seminoma: Why radiotherapy is better than carboplatin.
Yathiraj PH; Sharan K; Fernandes DJ; Vidyasagar MS
J Cancer Res Ther; 2016; 12(4):1216-1219. PubMed ID: 28169230
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
